SentiSense
Ctrl+K
Quick tip: Press
to search stocks
G
GEHC
GE HealthCare Technologies Inc.
$74.27
-2.84 (-3.68%)
Summary
Stories
News
Metrics
Fundamentals
Recent News
Filter:
Showing 11 of 11 articles
Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know - The Globe and Mail
Unknown
•
1 day ago
•
Negative
Patent Cliff + 10% FCF Yield. Is this a Value Trap?
Unknown
•
2 days ago
•
Neutral
Respiratory Disease Testing Market Global Forecast Report 2026-2032: $9.32 Bn Opportunities in Integrating Advanced Diagnostics, Leveraging Partnerships, and Enhancing Supply Resilience
GlobeNewswire Inc.
•
2 days ago
•
Positive
Jeannette Bankes (GEHC) receives stock options and RSUs from GE HealthCare - Stock Titan
Unknown
•
3 days ago
•
Neutral
GE Healthcare Stock at 80$: Why Analysts See 35% Upside - TIKR.com
Unknown
•
4 days ago
•
Neutral
Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes
Benzinga
•
4 days ago
•
Positive
GE Healthcare's Credit Facility Secures Financial Stability - Intellectia AI
Unknown
•
5 days ago
•
Positive
Waverton Investment Management Ltd Acquires 29,897 Shares of GE HealthCare Technologies Inc. $GEHC - MarketBeat
Unknown
•
5 days ago
•
Positive
RadNet Makes $270 Million Bet On AI Future With Gleamer Buyout
Benzinga
•
5 days ago
•
Positive
TD Asset Management Inc Acquires 14,675 Shares of GE HealthCare Technologies Inc. $GEHC - MarketBeat
Unknown
•
6 days ago
•
Positive
American Century Companies Inc. Grows Position in GE HealthCare Technologies Inc. $GEHC - MarketBeat
Unknown
•
6 days ago
•
Neutral
Company Profile
Symbol
GEHC
Market Cap
$33.85B
IPO Date
Dec 15, 2022
CEO
--
Employees
54,000
Sector
--
Industry
X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS
Country
United States
Exchange
--
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Read More